Skip to content

HIGHLIGHTS FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2022

By asianet

New research reported at the Alzheimer’s Association International Conference(R) ( https://aaic.alz.org/overview.asp ) (AAIC(R)) 2022 covered the breadth of Alzheimer’s and dementia research, including the basic biology of aging and the brain, risk factors and prevention strategies, and caregiving and living well with the disease. Logo – https://mma.prnewswire.com/media/1869584/AAIC22_purple_font_rgb_Logo.jpg AAIC is the premier annual forum for presentation … Continued

HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA

By asianet

Experiences of high blood pressure disorders during pregnancy are associated with an increased risk of vascular dementia and accelerated brain aging, according to studies reported today at the Alzheimer’s Association International Conference(R)) (AAIC(R)) 2022 ( https://c212.net/c/link/?t=0&l=en&o=3611257-1&h=4085809890&u=https%3A%2F%2Fwww.alz.org%2Faaic&a=Alzheimer%27s+Association+International+Conference ) in San Diego and virtually. Photo – https://mma.prnewswire.com/media/1871394/AAIC_Vascular_Dementia.jpg Logo – https://mma.prnewswire.com/media/1869584/AAIC22_purple_font_rgb_Logo.jpg Hypertensive disorders of pregnancy (HDP) — conditions … Continued

Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the Treatment of Rare Immunodeficiency, APDS

By asianet

EMA accelerated assessment allows a shorter review period for leniolisib from a standard 210 days to 150 days Pharming is on track to submit its Marketing Authorisation Application for leniolisib in H2 2022 Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM) (Nasdaq: PHAR) announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for … Continued

LOWER SOCIOECONOMIC STATUS IN CHILDHOOD, PERSISTENT LOW WAGES LINKED TO RISK FOR DEMENTIA AND FASTER MEMORY DECLINE

By asianet

Socioeconomic deprivation, including neighborhood disadvantages and persistent low wages, are associated with higher dementia risk, lower cognitive performance and faster memory decline, according to several studies reported today at the Alzheimer’s Association International Conference(R) (AAIC(R)) 2022 ( https://c212.net/c/link/?t=0&l=en&o=3608645-1&h=3881122162&u=https%3A%2F%2Fwww.alz.org%2Faaic&a=Alzheimer%27s+Association+International+Conference ) in San Diego and virtually. Socioeconomic status (SES) — reflecting both social and economic measures of … Continued

Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination

By asianet

Preclinical data support the potential of ONA-XR plus estrogen receptor degraders in endocrine resistant disease models Context to initiate Phase 1b/2 clinical trial in Q4 2022 Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a women’s oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, and The Menarini Group (“Menarini”) today … Continued

iHerb Achieves Customer Service Milestones

By asianet

-Users Highly Rate iHerb on Top Online Platforms iHerb, the world’s largest e-commerce platform dedicated to health and wellness, reached significant milestones last month. The company is excited to announce its ratings among Google Customers, Google Play Store, and the Apple App Store. With a 4.9 star rating on Google, 4.8 on Google Play Store … Continued

Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency

By asianet

— Implemented by the Centers for Disease Control and Prevention, the diagnosis code will accurately identify US patients with APDS, supporting care and research efforts Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that a new diagnosis code for reporting cases of activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary … Continued

Novel and fast typing method developed to control monkeypox by Molecular Biology Systems (MBS) in collaboration with the Amsterdam UMC and Danish Rigshospitalet

By asianet

In the worldwide effort to control monkeypox, a novel and fast typing method to trace monkeypox virus strains was developed by Dutch company Molecular Biology Systems (MBS) in collaboration with the department of Medical Microbiology & Infectious Disease Prevention of the Amsterdam UMC and researchers of the Danish Rigshospitalet. Apart from being fast, this new … Continued

EXPERIENCES OF RACISM ASSOCIATED WITH POOR MEMORY, INCREASED COGNITIVE DECLINE

By asianet

Experiences of structural, interpersonal and institutional racism are associated with lower memory scores and worse cognition in midlife and old age, especially among Black individuals, according to studies reported today at the Alzheimer’s Association International Conference(R) (AAIC(R)) 2022 [ https://c212.net/c/link/?t=0&l=en&o=3608630-1&h=3801775295&u=https%3A%2F%2Fwww.alz.org%2Faaic&a=Alzheimer%27s+Association+International+Conference ] in San Diego and virtually. Logo – https://mma.prnewswire.com/media/1869584/AAIC22_purple_font_rgb_Logo.jpg Among the key findings reported at … Continued

66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics’ VivoSight OCT laser scanner

By asianet

A major study published in leading cancer journal, The Lancet Oncology[1] have ground-breaking findings on Michelson Diagnostics, the UK based medical device company that use multi-beam Optical Coherence Tomography (‘OCT’) technology, which can transform patient’s treatment and care of basal cell carcinomas (BCC). It was concluded that OCT-guided diagnosis, when compared to a standard punch … Continued